Company Filing History:
1 out of 1,373 
1 out of 1,209 
Years Active: 2014
Title: Matthias Hofer: Innovator in Cancer Treatment
Introduction
Matthias Hofer is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of cancer treatment, particularly in the area of NUT midline carcinoma (NMC). His innovative approaches have the potential to improve patient outcomes and advance medical research.
Latest Patents
Matthias Hofer holds 1 patent related to methods of treating NUT midline carcinoma. The patent focuses on administering compounds that promote increased histone acetylation. Additionally, it includes assay methods for determining the responsiveness of NMC to specific histone deacetylases and other compounds.
Career Highlights
Throughout his career, Matthias has worked with prestigious institutions such as Brigham and Women's Hospital and Dana-Farber Cancer Institute. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Christopher French and Jon C. Aster. Their collaborative efforts have furthered the understanding and treatment of complex cancer types.
Conclusion
Matthias Hofer's contributions to cancer treatment through his innovative patent and collaborations with esteemed institutions highlight his commitment to advancing medical science. His work continues to inspire future research in the field.